Your browser doesn't support javascript.
loading
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles.
Martínez-Arranz, Ibon; Bruzzone, Chiara; Noureddin, Mazen; Gil-Redondo, Ruben; Mincholé, Itziar; Bizkarguenaga, Maider; Arretxe, Enara; Iruarrizaga-Lejarreta, Marta; Fernández-Ramos, David; Lopitz-Otsoa, Fernando; Mayo, Rebeca; Embade, Nieves; Newberry, Elizabeth; Mittendorf, Bettina; Izquierdo-Sánchez, Laura; Smid, Vaclav; Arnold, Jorge; Iruzubieta, Paula; Pérez Castaño, Ylenia; Krawczyk, Marcin; Marigorta, Urko M; Morrison, Martine C; Kleemann, Robert; Martín-Duce, Antonio; Hayardeny, Liat; Vitek, Libor; Bruha, Radan; Aller de la Fuente, Rocío; Crespo, Javier; Romero-Gomez, Manuel; Banales, Jesus M; Arrese, Marco; Cusi, Kenneth; Bugianesi, Elisabetta; Klein, Samuel; Lu, Shelly C; Anstee, Quentin M; Millet, Oscar; Davidson, Nicholas O; Alonso, Cristina; Mato, José M.
Afiliação
  • Martínez-Arranz I; OWL Metabolomics, Derio, Bizkaia, Spain.
  • Bruzzone C; CIC bioGUNE, BRTA, CIBERehd, Derio, Bizkaia, Spain.
  • Noureddin M; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Gil-Redondo R; CIC bioGUNE, BRTA, CIBERehd, Derio, Bizkaia, Spain.
  • Mincholé I; OWL Metabolomics, Derio, Bizkaia, Spain.
  • Bizkarguenaga M; CIC bioGUNE, BRTA, CIBERehd, Derio, Bizkaia, Spain.
  • Arretxe E; OWL Metabolomics, Derio, Bizkaia, Spain.
  • Iruarrizaga-Lejarreta M; OWL Metabolomics, Derio, Bizkaia, Spain.
  • Fernández-Ramos D; CIC bioGUNE, BRTA, CIBERehd, Derio, Bizkaia, Spain.
  • Lopitz-Otsoa F; CIC bioGUNE, BRTA, CIBERehd, Derio, Bizkaia, Spain.
  • Mayo R; OWL Metabolomics, Derio, Bizkaia, Spain.
  • Embade N; CIC bioGUNE, BRTA, CIBERehd, Derio, Bizkaia, Spain.
  • Newberry E; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Mittendorf B; Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Izquierdo-Sánchez L; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, Donostia, Spain.
  • Smid V; First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Arnold J; Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
  • Iruzubieta P; Marqués de Valdecilla University Hospital, Cantabria University, Santander, Spain.
  • Pérez Castaño Y; Department of Digestive System, Osakidetza Basque Health Service, Donostia University Hospital, San Sebastian, Spain.
  • Krawczyk M; Department of Medicine II, Saarland University Medical Center, Homburg, Germany.
  • Marigorta UM; Laboratory of Metabolic Liver Diseases, Center for Preclinical Research, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
  • Morrison MC; CIC bioGUNE, BRTA, CIBERehd, Derio, Bizkaia, Spain.
  • Kleemann R; Department of Metabolic Health Research, Netherlands Organization for Applied Scientific Research, Leiden, The Netherlands.
  • Martín-Duce A; Department of Metabolic Health Research, Netherlands Organization for Applied Scientific Research, Leiden, The Netherlands.
  • Hayardeny L; Alcalá University School of Medicine and Health Sciences, University Hospital Principe de Asturias, Madrid, Spain.
  • Vitek L; Galmed Pharmaceuticals, Tel Aviv, Israel.
  • Bruha R; First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Aller de la Fuente R; First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Crespo J; Department of Digestive Disease, Clinic University Hospital, University Hospital of Valladolid, Valladolid, Spain.
  • Romero-Gomez M; Marqués de Valdecilla University Hospital, Cantabria University, Santander, Spain.
  • Banales JM; Valme University Hospital, CiBERehd, Sevilla, Spain.
  • Arrese M; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, Donostia, Spain.
  • Cusi K; University of the Basque Country, CIBERehd, IKERBASQUE, Donostia, Spain.
  • Bugianesi E; Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
  • Klein S; Centro de Envejecimiento y Regeneración, Santiago, Chile.
  • Lu SC; Division of Endocrinology, Diabetes and Metabolism, University of Florida and Malcom Randall VAMC, Gainesville, Florida, USA.
  • Anstee QM; Gastroenterology Department, University of Turin, Turin, Italy.
  • Millet O; Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Davidson NO; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Alonso C; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Mato JM; Newcastle NIHR Biomedical Research Center, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle Upon Tyne, UK.
Hepatology ; 76(4): 1121-1134, 2022 10.
Article em En | MEDLINE | ID: mdl-35220605
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article